Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18
Enzolytics, Inc. today announced the execution of a non-binding letter of intent (the "LOI") to merge with
BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas. _________________________________________________________________
Table Data
ENZC - Sep 16 - Historical Price and Volume from Aug 28 thru Sep 18